Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
DLTR

Dollar Tree

$98.66

5.77 (6.21%)

, LLY

Eli Lilly

$115.98

1.33 (1.16%)

13:02
01/07/19
01/07
13:02
01/07/19
13:02
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened little…

DLTR

Dollar Tree

$98.66

5.77 (6.21%)

LLY

Eli Lilly

$115.98

1.33 (1.16%)

LOXO

Loxo Oncology

$231.60

91.78 (65.64%)

AAPL

Apple

$147.47

-0.8 (-0.54%)

SSNLF

Samsung

$0.00

(0.00%)

AGIO

Agios Pharmaceuticals

$50.39

3.62 (7.74%)

ARQL

ArQule

$3.34

0.15 (4.70%)

ARRY

Array BioPharma

$17.28

1.57 (9.99%)

BPMC

Blueprint Medicines

$61.96

8.48 (15.86%)

KURA

Kura Oncology

$15.87

0.75 (4.96%)

MRTX

Mirati Therapeutics

$46.85

1.91 (4.25%)

LXFT

Luxoft

$57.50

25.795 (81.36%)

DXC

DXC Technology

$57.53

0.2 (0.35%)

SAGE

Sage Therapeutics

$141.04

43.6 (44.75%)

PCG

PG&E

$18.99

-5.405 (-22.16%)

HCLP

Hi-Crush Partners

$3.67

-0.68 (-15.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 08

    Jan

  • 14

    Jan

  • 17

    Jan

  • 28

    Jan

  • 10

    Feb

  • 19

    Mar

  • 18

    May

LOXO

Loxo Oncology

$139.82

8.92 (6.81%)

, LLY

Eli Lilly

$114.65

3.36 (3.02%)

09:13
01/07/19
01/07
09:13
01/07/19
09:13
Recommendations
Loxo Oncology, Eli Lilly, Agios Pharmaceuticals, ArQule, Array BioPharma, Blueprint Medicines, Kura Oncology, Mirati Therapeutics analyst commentary at Piper Jaffray »

Piper Jaffray views price…

LOXO

Loxo Oncology

$139.82

8.92 (6.81%)

LLY

Eli Lilly

$114.65

3.36 (3.02%)

AGIO

Agios Pharmaceuticals

$46.77

0.9 (1.96%)

ARQL

ArQule

$3.19

0.46 (16.85%)

ARRY

Array BioPharma

$15.71

1.02 (6.94%)

BPMC

Blueprint Medicines

$53.48

4.69 (9.61%)

KURA

Kura Oncology

$15.12

0.67 (4.64%)

MRTX

Mirati Therapeutics

$44.94

1.03 (2.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 14

    Jan

  • 17

    Jan

  • 28

    Jan

  • 18

    May

BPMC

Blueprint Medicines

$48.79

-2.32 (-4.54%)

08:04
01/04/19
01/04
08:04
01/04/19
08:04
Hot Stocks
Blueprint Medicines announces '2020 Blueprint' global business strategy »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$57.43

0.66 (1.16%)

18:29
12/02/18
12/02
18:29
12/02/18
18:29
Hot Stocks
Blueprint Medicines announces updated results from ongoing EXPLORER trial »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

Over a quarter ago
DCPH

Deciphera

$22.61

1.99 (9.65%)

, BPMC

Blueprint Medicines

$52.33

-4.05 (-7.18%)

08:42
11/16/18
11/16
08:42
11/16/18
08:42
Recommendations
Deciphera, Blueprint Medicines analyst commentary at Leerink »

Deciphera price target…

DCPH

Deciphera

$22.61

1.99 (9.65%)

BPMC

Blueprint Medicines

$52.33

-4.05 (-7.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

BPMC

Blueprint Medicines

$52.33

-4.05 (-7.18%)

07:18
11/16/18
11/16
07:18
11/16/18
07:18
Recommendations
Blueprint Medicines analyst commentary at Wedbush »

Blueprint Medicines data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

DCPH

Deciphera

$22.50

1.88 (9.12%)

, BPMC

Blueprint Medicines

$54.16

-2.22 (-3.94%)

10:32
11/15/18
11/15
10:32
11/15/18
10:32
Recommendations
Deciphera, Blueprint Medicines analyst commentary at Piper Jaffray »

Deciphera remains well…

DCPH

Deciphera

$22.50

1.88 (9.12%)

BPMC

Blueprint Medicines

$54.16

-2.22 (-3.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

BPMC

Blueprint Medicines

$56.38

-3.89 (-6.45%)

07:25
11/15/18
11/15
07:25
11/15/18
07:25
Conference/Events
Blueprint Medicines to hold a conference call »

Management presents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BPMC

Blueprint Medicines

$56.38

-3.89 (-6.45%)

07:05
11/15/18
11/15
07:05
11/15/18
07:05
Hot Stocks
Blueprint Medicines updates avapritinib trial results for stomach tumors »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BPMC

Blueprint Medicines

$56.38

-3.89 (-6.45%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Blueprint Medicines to hold a conference call »

Management presents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.